An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.
India is the largest region of Active Pharmaceutical Ingredients (API), with a market share about 30%. Teva Active Pharmaceutical Industries Limited, DSM, Novartis, Roche and Johnson and Johnson are the top 5 manufacturers of industry.
The Global Active Pharmaceutical Ingredients API Market Size was estimated at USD 67774.47 million in 2021 and is projected to reach USD 127217.78 million by 2028, exhibiting a CAGR of 6.60% during the forecast period.
This report provides a deep insight into the global Active Pharmaceutical Ingredients API market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Active Pharmaceutical Ingredients API Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Active Pharmaceutical Ingredients API market in any manner.
Global Active Pharmaceutical Ingredients API Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
•Teva
•Mylan
•DSM
•Aurobindo Pharma
•Aspen
•Novartis
•BASF
•Pfizer
•Huahai Pharmaceutical
•Hisun Pharmaceutical
•Sun Pharmaceutical Industries
•Zhejiang Medicine
•Dr. Reddy’s Laboratories
•Zhejiang NHU
•Bayer
•NCPC
•AbbVie
•Shandong Xinhua Pharmaceutical
•Northeast Pharm
•Harbin Pharmaceutical
•LKPC
Market Segmentation (by Type)
•Synthetic APIs
•Biotech APIs
Market Segmentation (by Application)
•CNS
•Cardiovascular
•Genitourinary/Hormonal Drugs
•Respiratory
•Rheumatology
•Diabetes
•Oncology
•Others
Geographic Segmentation
• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Active Pharmaceutical Ingredients API Market
• Overview of the regional outlook of the Active Pharmaceutical Ingredients API Market:
Key Reasons to Buy this Report:
• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Active Pharmaceutical Ingredients API Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Active Pharmaceutical Ingredients API
1.2 Key Market Segments
1.2.1 Active Pharmaceutical Ingredients API Segment by Type
1.2.2 Active Pharmaceutical Ingredients API Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Active Pharmaceutical Ingredients API Market Overview
2.1 Global Market Overview
2.1.1 Global Active Pharmaceutical Ingredients API Market Size (M USD) Estimates and Forecasts (2017-2028)
2.1.2 Global Active Pharmaceutical Ingredients API Sales Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Active Pharmaceutical Ingredients API Market Competitive Landscape
3.1 Global Active Pharmaceutical Ingredients API Sales by Manufacturers (2017-2022)
3.2 Global Active Pharmaceutical Ingredients API Revenue Market Share by Manufacturers (2017-2022)
3.3 Active Pharmaceutical Ingredients API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Active Pharmaceutical Ingredients API Average Price by Manufacturers (2017-2022)
3.5 Manufacturers Active Pharmaceutical Ingredients API Sales Sites, Area Served, Product Type
3.6 Active Pharmaceutical Ingredients API Market Competitive Situation and Trends
3.6.1 Active Pharmaceutical Ingredients API Market Concentration Rate
3.6.2 Global 5 and 10 Largest Active Pharmaceutical Ingredients API Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Active Pharmaceutical Ingredients API Industry Chain Analysis
4.1 Active Pharmaceutical Ingredients API Industry Chain Analysis
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Active Pharmaceutical Ingredients API Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Active Pharmaceutical Ingredients API Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Active Pharmaceutical Ingredients API Sales Market Share by Type (2017-2022)
6.3 Global Active Pharmaceutical Ingredients API Market Size Market Share by Type (2017-2022)
6.4 Global Active Pharmaceutical Ingredients API Price by Type (2017-2022)
7 Active Pharmaceutical Ingredients API Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Active Pharmaceutical Ingredients API Market Sales by Application (2017-2022)
7.3 Global Active Pharmaceutical Ingredients API Market Size (M USD) by Application (2017-2022)
7.4 Global Active Pharmaceutical Ingredients API Sales Growth Rate by Application (2017-2022)
8 Active Pharmaceutical Ingredients API Market Segmentation by Region
8.1 Global Active Pharmaceutical Ingredients API Sales by Region
8.1.1 Global Active Pharmaceutical Ingredients API Sales by Region
8.1.2 Global Active Pharmaceutical Ingredients API Sales Market Share by Region
8.2 North America
8.2.1 North America Active Pharmaceutical Ingredients API Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Active Pharmaceutical Ingredients API Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Active Pharmaceutical Ingredients API Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Active Pharmaceutical Ingredients API Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Active Pharmaceutical Ingredients API Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profiled
9.1 Teva
9.1.1 Teva Active Pharmaceutical Ingredients API Basic Information
9.1.2 Teva Active Pharmaceutical Ingredients API Product Overview
9.1.3 Teva Active Pharmaceutical Ingredients API Product Market Performance
9.1.4 Teva Business Overview
9.1.5 Teva Active Pharmaceutical Ingredients API SWOT Analysis
9.1.6 Teva Recent Developments
9.2 Mylan
9.2.1 Mylan Active Pharmaceutical Ingredients API Basic Information
9.2.2 Mylan Active Pharmaceutical Ingredients API Product Overview
9.2.3 Mylan Active Pharmaceutical Ingredients API Product Market Performance
9.2.4 Mylan Business Overview
9.2.5 Mylan Active Pharmaceutical Ingredients API SWOT Analysis
9.2.6 Mylan Recent Developments
9.3 DSM
9.3.1 DSM Active Pharmaceutical Ingredients API Basic Information
9.3.2 DSM Active Pharmaceutical Ingredients API Product Overview
9.3.3 DSM Active Pharmaceutical Ingredients API Product Market Performance
9.3.4 DSM Business Overview
9.3.5 DSM Active Pharmaceutical Ingredients API SWOT Analysis
9.3.6 DSM Recent Developments
9.4 Aurobindo Pharma
9.4.1 Aurobindo Pharma Active Pharmaceutical Ingredients API Basic Information
9.4.2 Aurobindo Pharma Active Pharmaceutical Ingredients API Product Overview
9.4.3 Aurobindo Pharma Active Pharmaceutical Ingredients API Product Market Performance
9.4.4 Aurobindo Pharma Business Overview
9.4.5 Aurobindo Pharma Active Pharmaceutical Ingredients API SWOT Analysis
9.4.6 Aurobindo Pharma Recent Developments
9.5 Aspen
9.5.1 Aspen Active Pharmaceutical Ingredients API Basic Information
9.5.2 Aspen Active Pharmaceutical Ingredients API Product Overview
9.5.3 Aspen Active Pharmaceutical Ingredients API Product Market Performance
9.5.4 Aspen Business Overview
9.5.5 Aspen Active Pharmaceutical Ingredients API SWOT Analysis
9.5.6 Aspen Recent Developments
9.6 Novartis
9.6.1 Novartis Active Pharmaceutical Ingredients API Basic Information
9.6.2 Novartis Active Pharmaceutical Ingredients API Product Overview
9.6.3 Novartis Active Pharmaceutical Ingredients API Product Market Performance
9.6.4 Novartis Business Overview
9.6.5 Novartis Recent Developments
9.7 BASF
9.7.1 BASF Active Pharmaceutical Ingredients API Basic Information
9.7.2 BASF Active Pharmaceutical Ingredients API Product Overview
9.7.3 BASF Active Pharmaceutical Ingredients API Product Market Performance
9.7.4 BASF Business Overview
9.7.5 BASF Recent Developments
9.8 Pfizer
9.8.1 Pfizer Active Pharmaceutical Ingredients API Basic Information
9.8.2 Pfizer Active Pharmaceutical Ingredients API Product Overview
9.8.3 Pfizer Active Pharmaceutical Ingredients API Product Market Performance
9.8.4 Pfizer Business Overview
9.8.5 Pfizer Recent Developments
9.9 Huahai Pharmaceutical
9.9.1 Huahai Pharmaceutical Active Pharmaceutical Ingredients API Basic Information
9.9.2 Huahai Pharmaceutical Active Pharmaceutical Ingredients API Product Overview
9.9.3 Huahai Pharmaceutical Active Pharmaceutical Ingredients API Product Market Performance
9.9.4 Huahai Pharmaceutical Business Overview
9.9.5 Huahai Pharmaceutical Recent Developments
9.10 Hisun Pharmaceutical
9.10.1 Hisun Pharmaceutical Active Pharmaceutical Ingredients API Basic Information
9.10.2 Hisun Pharmaceutical Active Pharmaceutical Ingredients API Product Overview
9.10.3 Hisun Pharmaceutical Active Pharmaceutical Ingredients API Product Market Performance
9.10.4 Hisun Pharmaceutical Business Overview
9.10.5 Hisun Pharmaceutical Recent Developments
9.11 Sun Pharmaceutical Industries
9.11.1 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients API Basic Information
9.11.2 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients API Product Overview
9.11.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients API Product Market Performance
9.11.4 Sun Pharmaceutical Industries Business Overview
9.11.5 Sun Pharmaceutical Industries Recent Developments
9.12 Zhejiang Medicine
9.12.1 Zhejiang Medicine Active Pharmaceutical Ingredients API Basic Information
9.12.2 Zhejiang Medicine Active Pharmaceutical Ingredients API Product Overview
9.12.3 Zhejiang Medicine Active Pharmaceutical Ingredients API Product Market Performance
9.12.4 Zhejiang Medicine Business Overview
9.12.5 Zhejiang Medicine Recent Developments
9.13 Dr. Reddy’s Laboratories
9.13.1 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients API Basic Information
9.13.2 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients API Product Overview
9.13.3 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients API Product Market Performance
9.13.4 Dr. Reddy’s Laboratories Business Overview
9.13.5 Dr. Reddy’s Laboratories Recent Developments
9.14 Zhejiang NHU
9.14.1 Zhejiang NHU Active Pharmaceutical Ingredients API Basic Information
9.14.2 Zhejiang NHU Active Pharmaceutical Ingredients API Product Overview
9.14.3 Zhejiang NHU Active Pharmaceutical Ingredients API Product Market Performance
9.14.4 Zhejiang NHU Business Overview
9.14.5 Zhejiang NHU Recent Developments
9.15 Bayer
9.15.1 Bayer Active Pharmaceutical Ingredients API Basic Information
9.15.2 Bayer Active Pharmaceutical Ingredients API Product Overview
9.15.3 Bayer Active Pharmaceutical Ingredients API Product Market Performance
9.15.4 Bayer Business Overview
9.15.5 Bayer Recent Developments
9.16 NCPC
9.16.1 NCPC Active Pharmaceutical Ingredients API Basic Information
9.16.2 NCPC Active Pharmaceutical Ingredients API Product Overview
9.16.3 NCPC Active Pharmaceutical Ingredients API Product Market Performance
9.16.4 NCPC Business Overview
9.16.5 NCPC Recent Developments
9.17 AbbVie
9.17.1 AbbVie Active Pharmaceutical Ingredients API Basic Information
9.17.2 AbbVie Active Pharmaceutical Ingredients API Product Overview
9.17.3 AbbVie Active Pharmaceutical Ingredients API Product Market Performance
9.17.4 AbbVie Business Overview
9.17.5 AbbVie Recent Developments
9.18 Shandong Xinhua Pharmaceutical
9.18.1 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients API Basic Information
9.18.2 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients API Product Overview
9.18.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients API Product Market Performance
9.18.4 Shandong Xinhua Pharmaceutical Business Overview
9.18.5 Shandong Xinhua Pharmaceutical Recent Developments
9.19 Northeast Pharm
9.19.1 Northeast Pharm Active Pharmaceutical Ingredients API Basic Information
9.19.2 Northeast Pharm Active Pharmaceutical Ingredients API Product Overview
9.19.3 Northeast Pharm Active Pharmaceutical Ingredients API Product Market Performance
9.19.4 Northeast Pharm Business Overview
9.19.5 Northeast Pharm Recent Developments
9.20 Harbin Pharmaceutical
9.20.1 Harbin Pharmaceutical Active Pharmaceutical Ingredients API Basic Information
9.20.2 Harbin Pharmaceutical Active Pharmaceutical Ingredients API Product Overview
9.20.3 Harbin Pharmaceutical Active Pharmaceutical Ingredients API Product Market Performance
9.20.4 Harbin Pharmaceutical Business Overview
9.20.5 Harbin Pharmaceutical Recent Developments
9.21 LKPC
9.21.1 LKPC Active Pharmaceutical Ingredients API Basic Information
9.21.2 LKPC Active Pharmaceutical Ingredients API Product Overview
9.21.3 LKPC Active Pharmaceutical Ingredients API Product Market Performance
9.21.4 LKPC Business Overview
9.21.5 LKPC Recent Developments
10 Active Pharmaceutical Ingredients API Market Forecast by Region
10.1 Global Active Pharmaceutical Ingredients API Market Size Forecast
10.2 Global Active Pharmaceutical Ingredients API Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Active Pharmaceutical Ingredients API Market Size Forecast by Country
10.2.3 Asia Pacific Active Pharmaceutical Ingredients API Market Size Forecast by Region
10.2.4 South America Active Pharmaceutical Ingredients API Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Active Pharmaceutical Ingredients API by Country
11 Forecast Market by Type and by Application (2022-2028)
11.1 Global Active Pharmaceutical Ingredients API Market Forecast by Type (2022-2028)
11.1.1 Global Forecasted Sales of Active Pharmaceutical Ingredients API by Type (2022-2028)
11.1.2 Global Active Pharmaceutical Ingredients API Market Size Forecast by Type (2022-2028)
11.1.3 Global Forecasted Price of Active Pharmaceutical Ingredients API by Type (2022-2028)
11.2 Global Active Pharmaceutical Ingredients API Market Forecast by Application (2022-2028)
11.2.1 Global Active Pharmaceutical Ingredients API Sales (K MT) Forecast by Application
11.2.2 Global Active Pharmaceutical Ingredients API Market Size (M USD) Forecast by Application (2022-2028)
12 Conclusion and Key Findings
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Active Pharmaceutical Ingredients API Market Size (M USD) Comparison by Region (M USD)
Table 5. Global Active Pharmaceutical Ingredients API Sales (K MT) by Manufacturers (2017-2022)
Table 6. Global Active Pharmaceutical Ingredients API Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Active Pharmaceutical Ingredients API Revenue (M USD) by Manufacturers (2017-2022)
Table 8. Global Active Pharmaceutical Ingredients API Revenue Share by Manufacturers (2017-2022)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Active Pharmaceutical Ingredients API as of 2021)
Table 10. Global Market Active Pharmaceutical Ingredients API Average Price (USD/MT) of Key Manufacturers (2017-2022)
Table 11. Manufacturers Active Pharmaceutical Ingredients API Sales Sites and Area Served
Table 12. Manufacturers Active Pharmaceutical Ingredients API Product Type
Table 13. Global Active Pharmaceutical Ingredients API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Active Pharmaceutical Ingredients API
Table 16. Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Active Pharmaceutical Ingredients API Market Challenges
Table 22. Market Restraints
Table 23. Global Active Pharmaceutical Ingredients API Sales by Type (K MT)
Table 24. Global Active Pharmaceutical Ingredients API Market Size by Type (M USD)
Table 25. Global Active Pharmaceutical Ingredients API Sales (K MT) by Type (2017-2022)
Table 26. Global Active Pharmaceutical Ingredients API Sales Market Share by Type (2017-2022)
Table 27. Global Active Pharmaceutical Ingredients API Market Size (M USD) by Type (2017-2022)
Table 28. Global Active Pharmaceutical Ingredients API Market Size Share by Type (2017-2022)
Table 29. Global Active Pharmaceutical Ingredients API Price (USD/MT) by Type (2017-2022)
Table 30. Global Active Pharmaceutical Ingredients API Sales (K MT) by Application
Table 31. Global Active Pharmaceutical Ingredients API Market Size by Application
Table 32. Global Active Pharmaceutical Ingredients API Sales by Application (2017-2022) & (K MT)
Table 33. Global Active Pharmaceutical Ingredients API Sales Market Share by Application (2017-2022)
Table 34. Global Active Pharmaceutical Ingredients API Sales by Application (2017-2022) & (M USD)
Table 35. Global Active Pharmaceutical Ingredients API Market Share by Application (2017-2022)
Table 36. Global Active Pharmaceutical Ingredients API Sales Growth Rate by Application (2017-2022)
Table 37. Global Active Pharmaceutical Ingredients API Sales by Region (2017-2022) & (K MT)
Table 38. Global Active Pharmaceutical Ingredients API Sales Market Share by Region (2017-2022)
Table 39. North America Active Pharmaceutical Ingredients API Sales by Country (2017-2022) & (K MT)
Table 40. Europe Active Pharmaceutical Ingredients API Sales by Country (2017-2022) & (K MT)
Table 41. Asia Pacific Active Pharmaceutical Ingredients API Sales by Region (2017-2022) & (K MT)
Table 42. South America Active Pharmaceutical Ingredients API Sales by Country (2017-2022) & (K MT)
Table 43. Middle East and Africa Active Pharmaceutical Ingredients API Sales by Region (2017-2022) & (K MT)
Table 44. Teva Active Pharmaceutical Ingredients API Basic Information
Table 45. Teva Active Pharmaceutical Ingredients API Product Overview
Table 46. Teva Active Pharmaceutical Ingredients API Sales (K MT), Market Size (M USD), Price (USD/MT) and Gross Margin (2017-2022)
Table 47. Teva Business Overview
Table 48. Teva Active Pharmaceutical Ingredients API SWOT Analysis
Table 49. Teva Recent Developments
Table 50. Mylan Active Pharmaceutical Ingredients API Basic Information
Table 51. Mylan Active Pharmaceutical Ingredients API Product Overview
Table 52. Mylan Active Pharmaceutical Ingredients API Sales (K MT), Market Size (M USD), Price (USD/MT) and Gross Margin (2017-2022)
Table 53. Mylan Business Overview
Table 54. Mylan Active Pharmaceutical Ingredients API SWOT Analysis
Table 55. Mylan Recent Developments
Table 56. DSM Active Pharmaceutical Ingredients API Basic Information
Table 57. DSM Active Pharmaceutical Ingredients API Product Overview
Table 58. DSM Active Pharmaceutical Ingredients API Sales (K MT), Market Size (M USD), Price (USD/MT) and Gross Margin (2017-2022)
Table 59. DSM Business Overview
Table 60. DSM Active Pharmaceutical Ingredients API SWOT Analysis
Table 61. DSM Recent Developments
Table 62. Aurobindo Pharma Active Pharmaceutical Ingredients API Basic Information
Table 63. Aurobindo Pharma Active Pharmaceutical Ingredients API Product Overview
Table 64. Aurobindo Pharma Active Pharmaceutical Ingredients API Sales (K MT), Market Size (M USD), Price (USD/MT) and Gross Margin (2017-2022)
Table 65. Aurobindo Pharma Business Overview
Table 66. Aurobindo Pharma Active Pharmaceutical Ingredients API SWOT Analysis
Table 67. Aurobindo Pharma Recent Developments
Table 68. Aspen Active Pharmaceutical Ingredients API Basic Information
Table 69. Aspen Active Pharmaceutical Ingredients API Product Overview
Table 70. Aspen Active Pharmaceutical Ingredients API Sales (K MT), Market Size (M USD), Price (USD/MT) and Gross Margin (2017-2022)
Table 71. Aspen Business Overview
Table 72. Aspen Active Pharmaceutical Ingredients API SWOT Analysis
Table 73. Aspen Recent Developments
Table 74. Novartis Active Pharmaceutical Ingredients API Basic Information
Table 75. Novartis Active Pharmaceutical Ingredients API Product Overview
Table 76. Novartis Active Pharmaceutical Ingredients API Sales (K MT), Market Size (M USD), Price (USD/MT) and Gross Margin (2017-2022)
Table 77. Novartis Business Overview
Table 78. Novartis Recent Developments
Table 79. BASF Active Pharmaceutical Ingredients API Basic Information
Table 80. BASF Active Pharmaceutical Ingredients API Product Overview
Table 81. BASF Active Pharmaceutical Ingredients API Sales (K MT), Market Size (M USD), Price (USD/MT) and Gross Margin (2017-2022)
Table 82. BASF Business Overview
Table 83. BASF Recent Developments
Table 84. Pfizer Active Pharmaceutical Ingredients API Basic Information
Table 85. Pfizer Active Pharmaceutical Ingredients API Product Overview
Table 86. Pfizer Active Pharmaceutical Ingredients API Sales (K MT), Market Size (M USD), Price (USD/MT) and Gross Margin (2017-2022)
Table 87. Pfizer Business Overview
Table 88. Pfizer Recent Developments
Table 89. Huahai Pharmaceutical Active Pharmaceutical Ingredients API Basic Information
Table 90. Huahai Pharmaceutical Active Pharmaceutical Ingredients API Product Overview
Table 91. Huahai Pharmaceutical Active Pharmaceutical Ingredients API Sales (K MT), Market Size (M USD), Price (USD/MT) and Gross Margin (2017-2022)
Table 92. Huahai Pharmaceutical Business Overview
Table 93. Huahai Pharmaceutical Recent Developments
Table 94. Hisun Pharmaceutical Active Pharmaceutical Ingredients API Basic Information
Table 95. Hisun Pharmaceutical Active Pharmaceutical Ingredients API Product Overview
Table 96. Hisun Pharmaceutical Active Pharmaceutical Ingredients API Sales (K MT), Market Size (M USD), Price (USD/MT) and Gross Margin (2017-2022)
Table 97. Hisun Pharmaceutical Business Overview
Table 98. Hisun Pharmaceutical Recent Developments
Table 99. Sun Pharmaceutical Industries Active Pharmaceutical Ingredients API Basic Information
Table 100. Sun Pharmaceutical Industries Active Pharmaceutical Ingredients API Product Overview
Table 101. Sun Pharmaceutical Industries Active Pharmaceutical Ingredients API Sales (K MT), Market Size (M USD), Price (USD/MT) and Gross Margin (2017-2022)
Table 102. Sun Pharmaceutical Industries Business Overview
Table 103. Sun Pharmaceutical Industries Recent Developments
Table 104. Zhejiang Medicine Active Pharmaceutical Ingredients API Basic Information
Table 105. Zhejiang Medicine Active Pharmaceutical Ingredients API Product Overview
Table 106. Zhejiang Medicine Active Pharmaceutical Ingredients API Sales (K MT), Market Size (M USD), Price (USD/MT) and Gross Margin (2017-2022)
Table 107. Zhejiang Medicine Business Overview
Table 108. Zhejiang Medicine Recent Developments
Table 109. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients API Basic Information
Table 110. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients API Product Overview
Table 111. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients API Sales (K MT), Market Size (M USD), Price (USD/MT) and Gross Margin (2017-2022)
Table 112. Dr. Reddy’s Laboratories Business Overview
Table 113. Dr. Reddy’s Laboratories Recent Developments
Table 114. Zhejiang NHU Active Pharmaceutical Ingredients API Basic Information
Table 115. Zhejiang NHU Active Pharmaceutical Ingredients API Product Overview
Table 116. Zhejiang NHU Active Pharmaceutical Ingredients API Sales (K MT), Market Size (M USD), Price (USD/MT) and Gross Margin (2017-2022)
Table 117. Zhejiang NHU Business Overview
Table 118. Zhejiang NHU Recent Developments
Table 119. Bayer Active Pharmaceutical Ingredients API Basic Information
Table 120. Bayer Active Pharmaceutical Ingredients API Product Overview
Table 121. Bayer Active Pharmaceutical Ingredients API Sales (K MT), Market Size (M USD), Price (USD/MT) and Gross Margin (2017-2022)
Table 122. Bayer Business Overview
Table 123. Bayer Recent Developments
Table 124. NCPC Active Pharmaceutical Ingredients API Basic Information
Table 125. NCPC Active Pharmaceutical Ingredients API Product Overview
Table 126. NCPC Active Pharmaceutical Ingredients API Sales (K MT), Market Size (M USD), Price (USD/MT) and Gross Margin (2017-2022)
Table 127. NCPC Business Overview
Table 128. NCPC Recent Developments
Table 129. AbbVie Active Pharmaceutical Ingredients API Basic Information
Table 130. AbbVie Active Pharmaceutical Ingredients API Product Overview
Table 131. AbbVie Active Pharmaceutical Ingredients API Sales (K MT), Market Size (M USD), Price (USD/MT) and Gross Margin (2017-2022)
Table 132. AbbVie Business Overview
Table 133. AbbVie Recent Developments
Table 134. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients API Basic Information
Table 135. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients API Product Overview
Table 136. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients API Sales (K MT), Market Size (M USD), Price (USD/MT) and Gross Margin (2017-2022)
Table 137. Shandong Xinhua Pharmaceutical Business Overview
Table 138. Shandong Xinhua Pharmaceutical Recent Developments
Table 139. Northeast Pharm Active Pharmaceutical Ingredients API Basic Information
Table 140. Northeast Pharm Active Pharmaceutical Ingredients API Product Overview
Table 141. Northeast Pharm Active Pharmaceutical Ingredients API Sales (K MT), Market Size (M USD), Price (USD/MT) and Gross Margin (2017-2022)
Table 142. Northeast Pharm Business Overview
Table 143. Northeast Pharm Recent Developments
Table 144. Harbin Pharmaceutical Active Pharmaceutical Ingredients API Basic Information
Table 145. Harbin Pharmaceutical Active Pharmaceutical Ingredients API Product Overview
Table 146. Harbin Pharmaceutical Active Pharmaceutical Ingredients API Sales (K MT), Market Size (M USD), Price (USD/MT) and Gross Margin (2017-2022)
Table 147. Harbin Pharmaceutical Business Overview
Table 148. Harbin Pharmaceutical Recent Developments
Table 149. LKPC Active Pharmaceutical Ingredients API Basic Information
Table 150. LKPC Active Pharmaceutical Ingredients API Product Overview
Our reports with in-depth insights will equip you to succeed in your business plans.
Get instant access to the information you need to make the right decision.
Explore where opportunities lie for you and mitigate the risks.
We are one of the most trusted brands setting benchmarks of excellence.